1. Home
  2. NVCR vs PAYO Comparison

NVCR vs PAYO Comparison

Compare NVCR & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • PAYO
  • Stock Information
  • Founded
  • NVCR 2000
  • PAYO 2005
  • Country
  • NVCR Switzerland
  • PAYO United States
  • Employees
  • NVCR N/A
  • PAYO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • PAYO EDP Services
  • Sector
  • NVCR Health Care
  • PAYO Technology
  • Exchange
  • NVCR Nasdaq
  • PAYO Nasdaq
  • Market Cap
  • NVCR 1.9B
  • PAYO 2.5B
  • IPO Year
  • NVCR 2015
  • PAYO N/A
  • Fundamental
  • Price
  • NVCR $17.71
  • PAYO $6.98
  • Analyst Decision
  • NVCR Buy
  • PAYO Strong Buy
  • Analyst Count
  • NVCR 6
  • PAYO 8
  • Target Price
  • NVCR $32.83
  • PAYO $10.44
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • PAYO 2.6M
  • Earning Date
  • NVCR 07-24-2025
  • PAYO 08-06-2025
  • Dividend Yield
  • NVCR N/A
  • PAYO N/A
  • EPS Growth
  • NVCR N/A
  • PAYO N/A
  • EPS
  • NVCR N/A
  • PAYO 0.28
  • Revenue
  • NVCR $621,711,000.00
  • PAYO $996,150,000.00
  • Revenue This Year
  • NVCR $5.56
  • PAYO $4.32
  • Revenue Next Year
  • NVCR $9.19
  • PAYO $5.59
  • P/E Ratio
  • NVCR N/A
  • PAYO $24.89
  • Revenue Growth
  • NVCR 18.27
  • PAYO 14.86
  • 52 Week Low
  • NVCR $14.17
  • PAYO $5.03
  • 52 Week High
  • NVCR $34.13
  • PAYO $11.29
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 51.32
  • PAYO 55.09
  • Support Level
  • NVCR $17.53
  • PAYO $6.61
  • Resistance Level
  • NVCR $18.70
  • PAYO $6.95
  • Average True Range (ATR)
  • NVCR 0.72
  • PAYO 0.19
  • MACD
  • NVCR 0.09
  • PAYO 0.04
  • Stochastic Oscillator
  • NVCR 60.56
  • PAYO 82.96

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.

Share on Social Networks: